FDA approval, fundraising, and the reality of building in healthcare according to BioticsAI founder
Navigating the Complexities of Healthcare Innovation
Launching a startup in healthcare comes with challenges unlike those in most industries—long development timelines, strict regulations, and the constant need for clinical accuracy. Robhy Bustami, co-founder and CEO of BioticsAI, has firsthand experience confronting these obstacles while working to bring cutting-edge AI to prenatal ultrasound diagnostics.
A Careful Approach to Product and Regulation
BioticsAI took a disciplined approach from day one, integrating clinical validation and regulatory strategy with product development. Rather than rushing a prototype to market, the team worked closely with medical professionals, assembled extensive datasets, and conducted well-structured clinical studies. This thorough process enabled them to secure an initial working product for under $100,000 and eventually helped them win TechCrunch’s Startup Battlefield in 2023.
By collaborating early and often with FDA regulators through pre-submission meetings, BioticsAI was able to clarify study designs and meet regulatory expectations, reducing uncertainty along their journey. Despite these steps, the risk of non-approval is always present, making investor relations and company morale key concerns.
Team Motivation in a Long-Haul Environment
Maintaining enthusiasm within the team during lengthy development and approval processes was a critical challenge. BioticsAI prioritized clear alignment between its engineers, clinicians, and researchers, ensuring team members recognized and celebrated progress, even if outside their direct responsibilities. Frequent wins on research initiatives and partnerships provided tangible momentum during the years-long effort.
Looking Ahead: Deployment and Expansion
With FDA clearance granted, BioticsAI is now positioned to deploy its AI ultrasound technology in hospitals, with an eye on expanding further into reproductive health. Bustami’s experience underscores that while building in healthcare is not for the impatient, it offers the fulfilling chance to fundamentally improve patient care.
For a deeper look at BioticsAI’s story and strategies, read the full article on TechCrunch.
